Countdown to IPBC Korea 2023
Just one month until IP leaders will gather in Seoul for an agenda tackling policy developments, market trends, and commercial pressures
Just one month until IP leaders will gather in Seoul for an agenda tackling policy developments, market trends, and commercial pressures
Opinion: Popular attacks on America’s life sciences patent system are highly misleading
Chief IP officers at large and small companies – especially life sciences – are closely watching the case which promises to settle debate about what comprises sufficient enablement under Section 112
Senators Chris Coons and Thom Tillis – both pro-patentee – take the lead but it doesn’t mean bills will pass
14 March 2023
Saturday Opinion: USPTO Director Kathi Vidal’s sanctions are a good start, but more must be done to curb untoward behaviour going forward
11 March 2023
Response to IPQC continues a long-running and bitter feud between leadership and staff
10 March 2023
Ethical and transparent partnerships can help resolve pressing issues all while furthering a company’s goals and interests
08 March 2023
Potential initiatives to limit continuation practice are causing deep divides in the life sciences patent community – causing technology licensors and Big Tech to take sides
07 March 2023
Saturday Opinion: Disseminating covid diagnostics and therapeutics is critical, but attempting to do so via the TRIPS waiver extension is rife with unintended consequences
04 March 2023
The country’s highest court grappled with questions that are fundamental to the future of patent law
03 March 2023
The USPTO director shares her thoughts on life sciences IP rights and ongoing collaboration with the FDA
02 March 2023
Without significant reforms that restore the right to exclude, lower costs and clarify eligibility, SMEs will remain second class citizens and the big calls on FRAND and SEPs will be made in Europe
02 March 2023
Court of Appeal President Klaus Grabinski speaks exclusively to IAM as three-month countdown to the Unified Patent Court gets underway
01 March 2023
Unlock unlimited access to all IAM content